Animals as bioreactors - the future of pharmaceutical industry?
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
Biotechnology products and its application raise many controversies. Discussions are carried out where the supporters of GMO are underlining the qualities of genetically modified organisms, and sceptics are pointing the dangers that, in their perspective, are exceeding the benefits, in this article, we intend to show the qualities resulting from the use of transgenic animals to produce cheaper drugs, as biotechnology and genetic engineering methods gave the possibility to use animals as bioreactors.
Biotechnologia, vol.82, 3 (2008)-.
0860-7796 ; oai:rcin.org.pl:73375 ; IChB B-77
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Oct 2, 2020
Jun 19, 2019
4139
https://rcin.org.pl./publication/96103
Edition name | Date |
---|---|
Zwierzęta jako bioreaktory - przyszłość przemysłu farmaceutycznego? | Oct 2, 2020 |
Bąkowska-Żywicka, Kamilla Tyczewska, Agata
Kietrys, Anna M. Szopa, Aleksandra Bąkowska-Żywicka, Kamilla
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan